Tokyo Tape
Sign in
← Cytori Cell Research Institute

Half-year report · Q2

3750.TEDINET S100US7P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥91m2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥1.6bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥863m2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥407m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥354m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥420m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income−¥907m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥424m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥432m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax−¥419m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥432m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥138m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥443m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥433m2024-04-01 → 2024-09-30Cons.Profit loss
Net income−¥443m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥5.1bnat 2024-09-30Cons.Assets
Total assets¥5.8bnat 2024-03-31Cons.Assets
Total assets¥13.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥2.8bnat 2024-09-30Cons.Liabilities
Total liabilities¥3.0bnat 2024-03-31Cons.Liabilities
Net assets / equity¥2.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥2.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥2.2bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥522mat 2024-09-30Cons.Cash and deposits
Cash and deposits¥1.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥522mat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥208mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥673mat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥421m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥367m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥4m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥8.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥102m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥94m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-48.422024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.472023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.652023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.422023-04-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio41.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.3%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio14.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30−¥144m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2024-04-01 → 2024-09-30¥65m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2024-04-01 → 2024-09-30¥65m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2024-04-01 → 2024-09-30−¥206m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2024-04-01 → 2024-09-30¥27m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2024-04-01 → 2024-09-30¥27m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2024-04-01 → 2024-09-30−¥57m
—segment totalrevenue2024-04-01 → 2024-09-30¥91m
—segment totalrevenue external2024-04-01 → 2024-09-30¥91m
—segment totalsegment profit2024-04-01 → 2024-09-30−¥263m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥87m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-09-30−¥285m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-09-30¥17m
—segment totalrevenue2023-04-01 → 2023-09-30¥863m
—segment totalrevenue external2023-04-01 → 2023-09-30¥863m
—segment totalsegment profit2023-04-01 → 2023-09-30−¥267m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 444
ItemContextValueUnit
Valuation and translation adjustmentsPrior1YearInstant276000JPY
Valuation and translation adjustmentsCurrentQuarterInstant249000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant4791000JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant2795586000JPY
Net assetsCurrentQuarterInstant2338582000JPY
Liabilities and net assetsPrior1YearInstant5816334000JPY
Liabilities and net assetsCurrentQuarterInstant5146718000JPY
Net salesPrior1YTDDuration862531000JPY
Net salesCurrentYTDDuration91433000JPY
Cost of salesPrior1YTDDuration134423000JPY
Cost of salesCurrentYTDDuration54379000JPY
Gross profitPrior1YTDDuration728108000JPY
Gross profitCurrentYTDDuration37053000JPY
Experiment and research expenses sgaPrior1YTDDuration176774000JPY
Experiment and research expenses sgaCurrentYTDDuration90791000JPY
Other sgaPrior1YTDDuration905405000JPY
Other sgaCurrentYTDDuration353558000JPY
Selling general and administrative expensesPrior1YTDDuration1082180000JPY
Selling general and administrative expensesCurrentYTDDuration444349000JPY
Operating incomePrior1YTDDuration-354071000JPY
Operating incomeCurrentYTDDuration-407295000JPY
Interest and dividends income noiPrior1YTDDuration212000JPY
Interest and dividends income noiCurrentYTDDuration220000JPY
Commission fee noiPrior1YTDDuration－JPY
Commission fee noiCurrentYTDDuration19000000JPY
Insurance income noiPrior1YTDDuration3085000JPY
Insurance income noiCurrentYTDDuration964000JPY
Interest subsidy noiPrior1YTDDuration2167000JPY
Interest subsidy noiCurrentYTDDuration1793000JPY
Other noiPrior1YTDDuration4500000JPY
Other noiCurrentYTDDuration3925000JPY
Non operating incomePrior1YTDDuration9966000JPY
Non operating incomeCurrentYTDDuration25904000JPY
Interest expenses noePrior1YTDDuration79310000JPY
Interest expenses noeCurrentYTDDuration37467000JPY
Other noePrior1YTDDuration112000JPY
Other noeCurrentYTDDuration772000JPY
Non operating expensesPrior1YTDDuration79422000JPY
Non operating expensesCurrentYTDDuration38240000JPY
Ordinary incomePrior1YTDDuration-423528000JPY
Ordinary incomeCurrentYTDDuration-419631000JPY
Gain on sales of subsidiaries and affiliates stocks eiPrior1YTDDuration－JPY
Gain on sales of subsidiaries and affiliates stocks eiCurrentYTDDuration1930000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration1930000JPY
Equipment removal costs elPrior1YTDDuration－JPY
Equipment removal costs elCurrentYTDDuration15064000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass